DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Smaill JB, Gonzales AJ, Spicer JA. et al.
Tyrosine kinase inhibitors. 20. Optimization of substituted quinazoline and pyrido[3,4-d]pyrimidine derivatives as orally active, irreversible inhibitors of the epidermal growth factor receptor family.
J Med Chem 2016;
59 (17) 8103-8124
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.